scispace - formally typeset
M

Masanao Yajima

Researcher at Boston University

Publications -  29
Citations -  4925

Masanao Yajima is an academic researcher from Boston University. The author has contributed to research in topics: Computer science & Workflow. The author has an hindex of 11, co-authored 26 publications receiving 3070 citations. Previous affiliations of Masanao Yajima include Columbia University & Fred Hutchinson Cancer Research Center.

Papers
More filters
Journal ArticleDOI

MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

TL;DR: This work argues that the cellular detection rate, the fraction of genes expressed in a cell, should be adjusted for as a source of nuisance variation and provides gene set enrichment analysis tailored to single-cell data.
Journal ArticleDOI

Why we (usually) don't have to worry about multiple comparisons

TL;DR: In this article, the problem of multiple comparisons can disappear entirely when viewed from a hierarchical Bayesian perspective, and a multilevel model is proposed to address the multiple comparisons problem and also yield more efficient estimates.
Journal ArticleDOI

Multiple Imputation with Diagnostics (mi) in R: Opening Windows into the Black Box

TL;DR: The mi package in R has features that allow the user to get inside the imputation process and evaluate the reasonableness of the resulting models and imputations, and uses Bayesian models and weakly informative prior distributions to construct more stable estimates of imputation models.
Posted ContentDOI

MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA-seq data

TL;DR: A new methodology to analyze single-cell transcriptomic data is presented that models this bimodality within a coherent generalized linear modeling framework, and the cellular detection rate, the fraction of genes turned on in a cell, is introduced.
Journal ArticleDOI

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

TL;DR: It is shown that 3 months of rapamycin treatment is sufficient to increase life expectancy by up to 60% and improve measures of healthspan in middle-aged mice and this transient treatment is also associated with a remodeling of the microbiome, including dramatically increased prevalence of segmented filamentous bacteria in the small intestine.